Perinatal Mental Health Study (PMHS) India
- Conditions
- SomatizationDepressionPTSDAnxietySuicidal Ideation
- Interventions
- Diagnostic Test: Screening tools for common mental disorders
- Registration Number
- NCT05485701
- Lead Sponsor
- University of Oxford
- Brief Summary
The purpose of this observational study is to improve understanding of mental disorders among perinatal women in India.
- Detailed Description
The purpose of this observational study is to assess the mental health of perinatal women living in two low-income settings in India. The first phase will explore women's awareness of mental illness and acceptability of screening for mental disorders. The second phase will be a validation study, during which the psychometric properties of screening tools will be assessed against a gold standard. The third stage will comprise a cohort study, during which the prevalence of and risk factors for mental disorders among perinatal and non-perinatal women will be established.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 2332
For Phase 1 (qualitative study) and Phase 2 (validation study):
Pregnant women:
- Aged 18 to 45 years
- Currently pregnant (any trimester)
- Willing and able to give informed consent
Post-partum women:
- Aged 18 to 45 years
- Currently post-partum (between 1-12 months postpartum)
- Willing and able to give informed consent
Non-perinatal women:
- Aged 18 to 45 years
- Not currently pregnant and not given birth in the past 12 months
- Willing and able to give informed consent
For Phase 3 (prospective cohort study):
Perinatal women:
- Aged 18 to 45 years
- In early pregnancy (estimated gestational age <20 weeks) at recruitment
- Not planning to relocate for the duration of the study period
- Willing and able to give informed consent
- Expressed a willingness to continue to participate for the four planned visits
Non-perinatal women:
- Aged 18 to 45 years
- Not currently pregnant and not given birth in the last 12 months
- Not planning to relocate for the duration of the study period
- Willing and able to give informed consent
- Expressed a willingness to continue to participate for the four planned visits
The participant may not enter the study if:
- They have an acutely severe psychiatric illness which impairs their ability to take part in the study
- They are not willing or able to provide informed consent
Other than for current severe psychiatric illness which affects ability to participate in the study, we will not exclude any participant on the basis of current or prior physical, psychological or psychiatric co-morbidities so long as she is willing to participate, her ability to take part is not compromised and her ability to give informed consent is not impaired by these conditions.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Perinatal women Screening tools for common mental disorders Women will be recruited in their first trimester of pregnancy and followed-up until 6 months post-partum. This is the 'exposed' group. Non-perinatal women Screening tools for common mental disorders Non-perinatal women will be recruited as the 'non-exposed' group and followed-up over the same duration as the perinatal group.
- Primary Outcome Measures
Name Time Method Phase 3: Odds ratios (with 95% confidence intervals) for factors associated with common mental disorders among perinatal and non-perinatal women September 2023 - August 2024 During the cohort study, risk factors associated with mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.
Phase 1: Codes and themes relating to acceptability of screening for perinatal mental disorders To be completed by August 2022 These will be themes emerging from focus groups with women around awareness of perinatal mental disorders and acceptability of screening.
Phase 2: Psychometric properties of screening tools for common mental disorders September 2022 - August 2023 The psychometric properties (sensitivity, specificity, area under the receiver operating curve, optimal cut-off and accuracy) of eight screening tools in Kannada and Hindi will be established among three groups of women: pregnant, post-partum and non-perinatal.
Phase 3: Point prevalence, period prevalence and incidence (with 95% confidence intervals) of common mental disorders among perinatal and non-perinatal women September 2023 - August 2024 During the cohort study, prevalence and incidence of mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
National Institute of Mental Health and Neuro Sciences
🇮🇳Bengaluru, Karnataka, India
Dr Rajendra Prasad Government Medical College
🇮🇳Kangra, Himachal Pradesh, India